At Acelity, we are committed to demonstrating the safety and effectiveness of our products to patients, clinicians and regulatory bodies around the world through published research results.
As a globally diversified medical device company, many government authorities require animal testing in order to ensure new products are safe and effective for patients. Our innovation model relies on in vitro testing, laboratory testing and finite element modeling so that animal testing is performed sparingly.
When deemed necessary, all Acelity pre-clinical studies are conducted at the facilities of third party research organizations. These organizations are regularly audited and inspected to ensure strict adherence to government and industry guidelines regarding the ethical care of animals. This includes conducting appropriate, ethical, and safe research.
We will continue to innovate, enhancing the safety and efficacy of our products across the business while reinforcing our commitment to the principles of replacing, reducing and refining the use of animals in pre-clinical testing.